InMed Pharmaceuticals (INM) Return on Assets (2022 - 2025)
Historic Return on Assets for InMed Pharmaceuticals (INM) over the last 4 years, with Q4 2025 value amounting to 0.62%.
- InMed Pharmaceuticals' Return on Assets rose 2100.0% to 0.62% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.62%, marking a year-over-year increase of 2100.0%. This contributed to the annual value of 0.6% for FY2025, which is 0.0% changed from last year.
- According to the latest figures from Q4 2025, InMed Pharmaceuticals' Return on Assets is 0.62%, which was up 2100.0% from 0.57% recorded in Q3 2025.
- In the past 5 years, InMed Pharmaceuticals' Return on Assets ranged from a high of 0.42% in Q1 2024 and a low of 1.4% during Q3 2022
- For the 4-year period, InMed Pharmaceuticals' Return on Assets averaged around 0.77%, with its median value being 0.62% (2025).
- In the last 5 years, InMed Pharmaceuticals' Return on Assets surged by 8400bps in 2023 and then plummeted by -5100bps in 2025.
- Quarter analysis of 4 years shows InMed Pharmaceuticals' Return on Assets stood at 1.08% in 2022, then surged by 55bps to 0.49% in 2023, then plummeted by -72bps to 0.83% in 2024, then rose by 25bps to 0.62% in 2025.
- Its Return on Assets was 0.62% in Q4 2025, compared to 0.57% in Q3 2025 and 0.66% in Q2 2025.